Perindopril and Losartan Attenuate Pro-Coagulation Factors in Human Adipocytes Exposed to SARS Cov-2 Spike Protein

• Main Authors: Meity Ardiana, Meity, I. Gde Rurus Suryawan, -, Hanestya Okky Hermawan, -, Primasitha Maharany Harsoyo, -, Inna Maya Sufiyah, -, A. R. Muhammad, -, B.S.I. Zaini, -
• Format: Article PeerReviewed
• Language: English; English; English; Indonesian
• Published: Journal of physiology and pharmacology: an official journal of the Polish Physiological Society 2023
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/128442/1/19.%20Perindopril%20and%20Losartan.pdf; https://repository.unair.ac.id/128442/3/19.%20Perindopril%20and%20Losartan.pdf; https://repository.unair.ac.id/128442/4/19%20koresponden.pdf; https://repository.unair.ac.id/128442/9/17.%20karil.pdf; https://repository.unair.ac.id/128442/; https://pubmed.ncbi.nlm.nih.gov/37661180/#:~:text=This%20study%20indicated%20that%20both,COVID%2D19%2Drelated%20thrombosis.; https://doi.org/10.26402/jpp.2023.3.03
• Institution: Universitas Airlangga

Abstract Thrombotic events are highly prevalent in coronavirus disease 2019 (COVID-19), especially in patients presenting with risk factors of adverse outcomes such as obesity. Recently, the associations between the angiotensin converting enzyme 2 (ACE2) pathway and thrombosis have been reported. A...